<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; authorized</title>
	<atom:link href="http://www.tapanray.in/tag/authorized/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Would ‘Complex Generics’ Attract More ‘Authorized Generics’?</title>
		<link>http://www.tapanray.in/would-complex-generics-attract-more-authorized-generics/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=would-complex-generics-attract-more-authorized-generics</link>
		<comments>http://www.tapanray.in/would-complex-generics-attract-more-authorized-generics/#comments</comments>
		<pubDate>Mon, 28 Oct 2019 00:00:26 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[advantages]]></category>
		<category><![CDATA[authorized]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[Complex]]></category>
		<category><![CDATA[generics]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[initiatives]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[perception]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[speciality]]></category>
		<category><![CDATA[spoilsport]]></category>
		<category><![CDATA[Strategic]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[traditional]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9761</guid>
		<description><![CDATA[Despite increasing numbers of alleged scams involving generic drugs, both in the United States and also in India, even involving many large generic drug manufacturers, the traditional generic drug market, keeps growing globally. Although, the current growth is in mid-single &#8230; <a href="http://www.tapanray.in/would-complex-generics-attract-more-authorized-generics/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/would-complex-generics-attract-more-authorized-generics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why Try To Reinvent The Wheel With So Much Of Hullabaloo?</title>
		<link>http://www.tapanray.in/why-try-to-reinvent-the-wheel-with-so-much-of-hullabaloo/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=why-try-to-reinvent-the-wheel-with-so-much-of-hullabaloo</link>
		<comments>http://www.tapanray.in/why-try-to-reinvent-the-wheel-with-so-much-of-hullabaloo/#comments</comments>
		<pubDate>Wed, 19 Mar 2014 00:00:07 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Ahluwalia]]></category>
		<category><![CDATA[authorized]]></category>
		<category><![CDATA[commission]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[HLEG]]></category>
		<category><![CDATA[hullabaloo]]></category>
		<category><![CDATA[IMS]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Montek]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PHFI]]></category>
		<category><![CDATA[Planning]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Reddy]]></category>
		<category><![CDATA[reinvent]]></category>
		<category><![CDATA[Singh]]></category>
		<category><![CDATA[Srinath]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[UHC]]></category>
		<category><![CDATA[wheel]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=5112</guid>
		<description><![CDATA[A recent IMS study, apparently ‘authorized’ (whatever it means) by the Planning Commission of India has reportedly suggested various ‘ways to make drugs affordable in India’. Though there does not appear to be anything new in the reported suggestions, the &#8230; <a href="http://www.tapanray.in/why-try-to-reinvent-the-wheel-with-so-much-of-hullabaloo/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/why-try-to-reinvent-the-wheel-with-so-much-of-hullabaloo/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
